About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: January 2008
Impact of Approvable Letters 2007 – Part 2
Yesterday I posted about the impact of approvable letters and began by saying I have not yet been able to compare this year to other years, but my gut told me that it was a higher rate of approvables than … Continue reading
Posted in Approvable Letters
2 Comments
Impact of Approvable Letters 2007 – Part 1
I do not currently have a way of counting and comparing the number of approvable letters issued over the past few years, but my gut tells me that 2007 was a banner year. I am currently compiling the 2007 list … Continue reading
Posted in Approvable Letters
Comments Off on Impact of Approvable Letters 2007 – Part 1
Stakeholders (or Steakholders!) and Cloned Food Products – When Safety Is Not Enough
Last week, the media carried reports stating that the agency was getting ready to announce that it was satisfied that the science regarding cloned food demonstrated no safety issues. It is really not clear what that means for the timing … Continue reading
Posted in FDA Policy, Food
Comments Off on Stakeholders (or Steakholders!) and Cloned Food Products – When Safety Is Not Enough
Election Resource
As we kick off the new year, we also kick off an election cycle. Accordingly, my colleagues in Public Affairs at Fleishman Hillard put together a handy little tool providing an overview of the election 2008 that I wanted to … Continue reading
Posted in Useful Resources
Comments Off on Election Resource
Iowa – What Does it Mean for Healthcare?
People want change. Barack to the Future! Huckabee a Wannabe! Those are my slogans. Barack Obama and Mike Huckabee are the winners according to CNN at this writing. What does that mean for healthcare? In my analysis of the past … Continue reading
Posted in Current Affairs
1 Comment